Research
Our research team is involved in numerous studies to determine causes, identify predictors, and develop treatments for serious mental illness in veterans. For information about faculty members' current and past research portfolios, please click on the faculty names.
Marianne Goodman, MD, Acting Director
Dr. Goodman is principal investigator on the projects below.
Group ("Project Life Force") vs. Individual Suicide Safety Planning RCT (2018-2023). Funding source: VA.
Pilot Study of Open Label, Intranasal Ketamine for Suicidal Ideation in Veterans (2019-2021). Funding source: VA.
The Needs of Adult Children Regarding a Suicide Attempt of the Veteran Parent: A Qualitative Study (2018-2020). Funding source: VA.
Safer: A Brief Intervention Involving Family Members in Suicide Safety Planning (2017-2020). Funding source: VA.
Suicide Safety Planning Group Treatment: "Project Life Force" (2015-2018). Funding source: VA.
Dr. Goodman is a local site investigator on the project below.
Using Telehealth to Improve Outcomes in Veterans at Risk for Suicide (2018-2020). Funding source: American Foundation for Suicide Prevention.
Joseph Geraci, PhD, LMHC, Director of Education
Dr. Geraci is principal investigator on the projects below.
VA Veteran Cultural Competence Certification Training. Funding source: Starbucks; NY State Health Foundation.
Westchester County Drug Enhancement Court: Veteran Treatment Track and Medicated Assisted Treatment (2017-2020). Funding source: Substance Abuse and Mental Health Services Administration / New York State Unified Court System.
Trained, Peer Mentorship and Veteran Support Organization Membership to Assist Transitioning Veterans: A Multi-arm, Parallel Randomized Controlled Trial (2014-2018). Funding source: David and Maureen O’Connor Foundation.
Geraci is co-investigator on the project below.
A Brief Peer-Support Cognitive Behavioral Intervention for Military Life Transitions (Mil-iTransition) Following Medical and Physical Evaluation Boards. Funding source: Military Suicide Research Consortium.
Vahram Haroutunian, PhD, Director of Research
Dr. Haroutunian is principal investigator on the projects below.
The 3D Genome in Transcriptional Regulation Across The Postnatal Life Span, With Implications for Schizophrenia and Bipolar Disorder(2018-2023). Funding source: NIMH.
Integrative Network Modeling of Cognitive Resilience to Alzheimer's Disease(2017-2022). Funding source: NIA.
Towards a Comprehensive Signaling Pathway Map of Parahippocampal Vulnerability in Alzheimers Disease(2017-2020). Funding source: NIA.
Sheep Request for Fluorescence Activated Cell Sorter (FACS; MOFLO ASTRIOS EQ)(2018). Funding source: VA.
Chi Chan, PhD, Fellowship Director
Dr. Chan is on the research team on the projects below.
PI: Dr Szeszko: Predicting Suicidal Behavior in Veterans with Bipolar Disorder Using Behavioral and Neuroimaging Based Impulsivity Phenotypes
PI: Dr Hazlett: CTBI: Traumatic Brain Injury-Induced Inflammation Effects on Cognitive Evaluations and Response Inhibition: Mechanisms of Increased Risk for Suicidality
Lisa Dixon, MD, MPH, Director of Clinical and Health Services Research
Dr. Dixon is principal investigator on the projects below.
OnTrackChile for First Episode Psychosis (2018-2023). Funding source: NIMH.
Web‐Based Therapist Training on Complicated Grief (2019-2021). Funding source: NIMH.
OnTrack: An Online Role-Playing Game (2017-2020). Funding source: NIMH.
VISN 5 MIRECC (2016-2020). Funding source: VA Maryland Health Center.
OnTrack>An Online Role-Playing Game(2014-2020). Funding source: NIMH.
ACT Training (2009-2020). Funding source: NYS-OMH.
Center for Practice Innovations (2007-2020). Funding source: NYS-OMH.
OnTrackNY with the Option of Social Network Meetings, Foundation for Excellence in Mental Health
Care (2017-2019). Funding source: Foundation for Excellence in Mental Health Care
IPA for VISN 3 MIRECC (2016-2019). Funding source: JJP VA Medical Center.
Improving Life Trajectories for Youth With Early Psychosis(2014-2019). Funding source: SAMHSA.
Dr. Dixon is collaborator, co-investigator, co-mentor, or consultant on the projects below.
PrOSPECT: Prevention of Symptoms and Psychosis Through Education and Cognitive Therapy (2018-2022). Funding source: SAMHSA.
Statistical Methods for the Assessment of Social Engagement in Psychosis Using Digital
Technologies (2018-2022). Funding source: NIMH.
Preventing Postpartum Depression: A Dyadic Approach adjunctive to Obstetric Care (2017-2022). Funding source: NIH.
The Neurobiology of Violence in a Psychosis-Risk Cohort (2017-2022). Funding source: NIMH.
Early Intervention Mental Health Demonstration Study, Social Security Administration (2016-2022). Funding source: Social Security Administration.
Promoting Hope and Opportunities for Youth with Early Psychosis (2019-2021). Funding source: SAMHSA.
Does the Addition of Cognitive Remediation to Coordinated Specialty Care Service Improve Functional Outcome? (2018-2021). Funding source: NIMH.
Optimizing and Personalizing Interventions for Schizophrenia Across the Lifespan (OPAL) (2018-2021). Funding source: NIMH.
Hospital Discharge Planning and Transition to Outpatient Psychiatric Care (2016-2021). Funding source: NIMH.
Zero Suicide Implementation and Evaluation in Outpatient Mental Health Clinics (2016-2021). Funding source: NIMH.
Addressing Psychiatrist Workforce Shortages in the U.S. with Psychiatric Advanced Practice Registered Nurses (2017-2020). Funding source: NIMH.
Early Stage Identification and Engagement to Reduce Duration of Untreated Psychosis (EaSIE) (2017-2020). Funding source: NIMH.
Family psychoeducation for adults with psychotic disorders in Tanzania (2017-2020). Funding source: NIMH.
CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated
Specialty Care (2016-2020). Funding source: NIMH.
Suicide Prevention Training (2014-2020). Funding source: NYS-OMH.
COD Training (2009-2020). Funding source: NYS-OMH.
A Trial of Opening Doors to Recovery for Persons with Serious Mental Illness (2017-2019). Funding source: NIMH.
Development of an Evidence-Based Evaluation for Life is Precious™: Phase II, New York Community Trust (2017-2019). Funding source: New York Community Trust.
Recovery to Practice (2014-2019). Funding source: SAMHSA via AHP.
Dr. Corcoran is principal investigator on the projects below.
Using the RDOC Approach to Understand Thought Disorder: A Linguistic Corpus-Based Approach(2018-2021). Funding source: NIMH.
Dr. Dracheva is principal investigator on the projects below.
The 3D Genome in Transcriptional Regulation Across the Postnatal Life Span, With Implications for Schizophrenia and Bipolar Disorder(2018-2023). Funding source: NIMH.
Cell Specificity of the Human Heroin Epigenome(2017-2022). Funding source: NIDA.
The Role of ADAR2-Associated RNA Editing in Pathogenesis of ALS(2017-2021). Funding source: VA.
Neuronal Subtype Specific Epigenetic Regulation in Schizophrenia(2016-2020). Funding source: VA.
Dr. Edwards is principal investigator on the projects below.
Dialectical Behavior Therapy for Justice-Involved Veterans: Feasibility, Acceptability, and Preliminary Efficacy (Funding Source: VA)
Westchester County Veterans Treatment Court Program Evaluation (Funding Source: NYS Unified Court System)
Qualitative Insights into Veteran Transitional Stress and Suicide (Funding Source: VISN 2 MIRECC)
Dr. Hazlett is principal investigator on the projects below.
CSR&D Research Career Scientist Award Application(2018-2023). Funding source: VA.
Group (“Project Life Force”) vs. Individual Suicide Safety Planning RCT (2018-2023). Funding source: VA.
Neurobiology of Affective Instability in Veterans at Low and High Risk for Suicide(2017-2021). Funding source: VA
Supplement to Neurobiology of Affective Instability in Veterans at Low and High Risk for Suicide(2019-2020). Funding source: VA.
DNA Methylation and Inflammatory Signatures with Suicide Risk and Treatment in US Veterans (2016-2020). Funding source: VA.
Supplement to Neurobiology of Affective Instability in Veterans at Low and High Risk for Suicide(2018-2019). Funding source: VA.
Dr. Kimhy is principal investigator on the projects below.
Optimizing and Personalizing Interventions for Schizophrenia Across the LifeSpan (2018-2022). Funding source: NIMH.
Improving Cognition via Exercise in Schizophrenia(2017-2021). Funding source: NIMH.
The Influence of Aerobic Exercise on Cognitive Functioning in Schizophrenia (2012-2015). Funding source: NIMH.
Psychosis in Schizophrenia: Mechanisms of Recovery(2007-2012). Funding source: NIMH.
The Influence of Arousal on Paranoia in Schizophrenia: An Experience Sampling Study (2009-2011). Funding source: NIMH.
Dr. Kimhy is co- investigator on the projects below.
Hippocampal Inflammation as a Pathophysiology for Psychosis (2017-2022). Funding source: NIMH.
Using the RDoC to Understand Thought Disorder: A Linguistic Corpus-Based Approach (2018-2021). Funding source: NIMH.
Thought Disorder and Social Cognition in Clinical Risk States for Schizophrenia (2017-2021). Funding source: NIMH.
Dr. Landa is principal investigator on the projects below.
Prevention of Symptoms and Psychosis through Education and Cognitive Therapy (ProSPECT) (2018-2022). Funding source: SAMHSA
Early Stage Identification and Engagement to Reduce Duration of Untreated Psychosis (EaSIE) (2017-2020). Funding source: NIMH.
Missouri System of Care Community Enhancement for Early Signs and Symptoms (SOC-SESS) (2016-2020). Funding source: SAMHSA.
Group and Family Based CBT for Youth at Risk for Psychosis: Virtual Patient-Avatar to Assist Caregiver (2014-2020). Funding source: Sidney R. Baer Jr. Foundation Award
Dr. Murrough is principal investigator on the projects below.
Transdiagnostic Multimodal 7 Tesla MRI of the Locus Coeruleus in Human Pathological Anxiety (2019-2024). Funding source: NIMH.
Electroconvulsive Therapy vs. Ketamine Treatment for Antidepressant Treatment Resistant Depression (2016-2022). Role: Mount Sinai Site Principal Investigator. Funding source: PCORI.
Neuro-Immune Biotypes of Depression: Towards Pathophysiology-Based Diagnosis and Personalized Treatment (2018-2021). Funding source: Dana Foundation.
Developing Neuronal KCNQ Channel Modulators For Mood Disorders (2017-2019). Funding source: NIH/NIMH.
Inflammatory and Neurocircuit Mechanisms of Anhedonia in Human Depression (2016-2018). Funding source: NIH/NIMH.
Functional MRI Studies of Emotion in Depression and Rapid Antidepressant Response (2011-2016). Funding source: NIH/NIMH.
Dr. Murrough is co-investigator on the projects below.
Neuroimaging of Resilience in World Trade Center Responders: A Focus on Emotional Processing, Reward and Social Cognition (2017-2021). Funding source: NIOSH.
7T MRI to reveal structural, connectomic and metabolic imaging markers for the neurobiology of depression (2016-2021). Funding source: NIH/NIMH.
Stress and atherosclerotic plaque macrophages – a systems biology approach (2016-2021). Funding source: NIH/NHLBI.
Dr. Roussos is principal investigator on the projects below.
Higher Order Chromatin and Genetic Risk for Alzheimer's Disease (2021-2026)
Multiethnic genomic, epigenomic and transcriptomic fine-mapping and functional validation analysis of schizophrenia and bipolar disorder risk loci (2021-2025)
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease (2020-2025)
A regulome and transcriptome atlas of fetal and adult human neurogenesis (2021-2024)
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease (2019-2024)
The 3D genome in transcriptional regulation across the postnatal life span, with implications for schizophrenia and bipolar disorder (2018-2023)
Single-nucleus transcriptome profiling across multiple brain regions in Parkinson's Disease (2021-2022)
Dr. Sokol is principal investigator on the projects below.
Development of a Recovery Oriented Treatment for Post Acute Suicidal Episode (PASE) Veterans (2021-2026) Funding source: VA
Dr. Szeszko is co-investigator on the projects below.
Longitudinal neuroimaging and neurocognitive assessment of risk and protective factors across the schizophrenia spectrum (2020-2024)
Predicting Suicidal Behavior in Veterans with Bipolar Disorder using Behavioral and Neuroimaging Based Impulsivity Phenotypes (2020-2024)
